RT Book, Section
A1 Gruenberg, Katherine
A1 Guglielmo, B. Joseph
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1193122099
T1 Antituberculous Medications
T2 Current Medical Diagnosis & Treatment 2023
YR 2023
FD 2023
PB McGraw-Hill Education
PP New York, NY
SN 9781264687343
LK accessmedicine.mhmedical.com/content.aspx?aid=1193122099
RD 2024/10/14
AB Mycobacteria  are  intracellular,  have  long  periods  of  metabolic  inactivity,  and  tend  to  develop  resistance  to  any  one  medication.  Therefore,  combined  medication  therapy  is  used  to  delay  the  emergence  of  resistance.  First-line  medications,  increasingly  used  together  in  the  treatment  of  tuberculosis,  are  isoniazid,  ethambutol,  rifampin,  and  pyrazinamide.